Literature DB >> 19853600

Tumor endothelial marker 5 expression in endothelial cells during capillary morphogenesis is induced by the small GTPase Rac and mediates contact inhibition of cell proliferation.

Mario Vallon1, Franziska Rohde, Klaus-Peter Janssen, Markus Essler.   

Abstract

Tumor endothelial marker (TEM) 5 is an adhesion G-protein-coupled receptor upregulated in endothelial cells during tumor and physiologic angiogenesis. So far, the mechanisms leading to upregulation of TEM5 and its function during angiogenesis have not been identified. Here, we report that TEM5 expression in endothelial cells is induced during capillary-like network formation on Matrigel, during capillary morphogenesis in a three-dimensional collagen I matrix, and upon confluence on a two-dimensional matrix. TEM5 expression was not induced by a variety of soluble angiogenic factors, including VEGF and bFGF, in subconfluent endothelial cells. TEM5 upregulation was blocked by toxin B from Clostridium difficile, an inhibitor of the small GTPases Rho, Rac, and Cdc42. The Rho inhibitor C3 transferase from Clostridium botulinum did not affect TEM5 expression, whereas the Rac inhibitor NSC23766 suppressed TEM5 upregulation. An excess of the soluble TEM5 extracellular domain or an inhibitory monoclonal TEM5 antibody blocked contact inhibition of endothelial cell proliferation resulting in multilayered islands within the endothelial monolayer and increased vessel density during capillary formation. Based on our results we conclude that TEM5 expression during capillary morphogenesis is induced by the small GTPase Rac and mediates contact inhibition of proliferation in endothelial cells. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853600     DOI: 10.1016/j.yexcr.2009.10.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor.

Authors:  Keith D Anderson; Li Pan; Xiao-man Yang; Virginia C Hughes; Johnathon R Walls; Melissa G Dominguez; Mary V Simmons; Patricia Burfeind; Yingzi Xue; Yi Wei; Lynn E Macdonald; Gavin Thurston; Christopher Daly; Hsin Chieh Lin; Aris N Economides; David M Valenzuela; Andrew J Murphy; George D Yancopoulos; Nicholas W Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 2.  The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases.

Authors:  Mingming Zhao; Zheyu Wang; Ming Yang; Yan Ding; Ming Zhao; Haijing Wu; Yan Zhang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-07       Impact factor: 8.667

3.  Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest.

Authors:  Mario Vallon; Christof Seidl; Birgit Blechert; Zhoulei Li; Klaus-Peter Gilbertz; Anja Baumgart; Michaela Aichler; Annette Feuchtinger; Florian C Gaertner; Frank Bruchertseifer; Alfred Morgenstern; Axel K Walch; Reingard Senekowitsch-Schmidtke; Markus Essler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-08       Impact factor: 9.236

4.  GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling.

Authors:  Ekaterina Posokhova; Animesh Shukla; Steven Seaman; Suresh Volate; Mary Beth Hilton; Bofan Wu; Holly Morris; Deborah A Swing; Ming Zhou; Enrique Zudaire; Jeffrey S Rubin; Brad St Croix
Journal:  Cell Rep       Date:  2014-12-31       Impact factor: 9.423

5.  GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation.

Authors:  Allison E Cherry; Juan Jesus Vicente; Cong Xu; Richard S Morrison; Shao-En Ong; Linda Wordeman; Nephi Stella
Journal:  Glia       Date:  2019-05-06       Impact factor: 7.452

6.  G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation.

Authors:  Shantel Weinsheimer; Ari D Brettman; Ludmila Pawlikowska; D Christine Wu; Michael R Mancuso; Frank Kuhnert; Michael T Lawton; Stephen Sidney; Jonathan G Zaroff; Charles E McCulloch; William L Young; Calvin Kuo; Helen Kim
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

7.  Characterization of differentially expressed genes involved in pathways associated with gastric cancer.

Authors:  Hao Li; Beiqin Yu; Jianfang Li; Liping Su; Min Yan; Jun Zhang; Chen Li; Zhenggang Zhu; Bingya Liu
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

8.  α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma.

Authors:  Katharina Teiluf; Christof Seidl; Birgit Blechert; Florian C Gaertner; Klaus-Peter Gilbertz; Vanesa Fernandez; Florian Bassermann; Jan Endell; Rainer Boxhammer; Stephane Leclair; Mario Vallon; Michaela Aichler; Annette Feuchtinger; Frank Bruchertseifer; Alfred Morgenstern; Markus Essler
Journal:  Oncotarget       Date:  2015-03-10

Review 9.  Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective Candidates.

Authors:  Łukasz Pietrzyk
Journal:  Dis Markers       Date:  2016-11-14       Impact factor: 3.434

10.  A RECK-WNT7 Receptor-Ligand Interaction Enables Isoform-Specific Regulation of Wnt Bioavailability.

Authors:  Mario Vallon; Kanako Yuki; Thi D Nguyen; Junlei Chang; Jenny Yuan; Dirk Siepe; Yi Miao; Markus Essler; Makoto Noda; K Christopher Garcia; Calvin J Kuo
Journal:  Cell Rep       Date:  2018-10-09       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.